NCT02975154

Brief Summary

This study evaluates the effect of Microcurrent Therapy in the treatment of osteoarthritis of the knee. Patients will be randomized to four groups: Group 1 and 2 both will receive Microcurrent Therapy, but different currents will be used. Group 3 will receive treatment with the Microcurrent treatment apparatus, but without any current. Group 4 will be a control group without specific interventions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2016

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 21, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 29, 2016

Completed
6 days until next milestone

Study Start

First participant enrolled

December 5, 2016

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 4, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 4, 2017

Completed
Last Updated

October 12, 2017

Status Verified

October 1, 2017

Enrollment Period

9 months

First QC Date

November 21, 2016

Last Update Submit

October 11, 2017

Conditions

Keywords

osteoarthritismicrocurrentkneeelectrotherapy

Outcome Measures

Primary Outcomes (1)

  • Numerical Ratings scale (NRS) for pain (0-10)

    numerical Rating scale

    Change of NRS: Before treatment vs. end of treatment (in average 21 days later)

Secondary Outcomes (6)

  • Knee injury and Osteoarthritis Outcome Score

    Change of scores: Before treatment vs. end of treatment (in average 21 days later)

  • Short-Form 36

    Change of scores: Before treatment vs. end of treatment (in average 21 days later)

  • Satisfaction with Treatment (Questionnaire)

    Evaluation at the end of treatment (in average 21 days after Start of treatment)

  • Range of Motion knee joint

    Change: Before treatment vs. end of treatment (in average 21 days later)

  • Get-up-and-Go-Test (GUG)

    Change: Before treatment vs. end of treatment (in average 21 days later)

  • +1 more secondary outcomes

Study Arms (4)

Microcurrent therapy, type A

ACTIVE COMPARATOR

Microcurrent therapy: Channel A: 100 µA; 200 Hz; Channel B: 100 µA; 300 Hz. Duration of each treatment session: 30 minutes. Number of sessions: 10. Previous treatments will be continued.

Device: Microcurrent therapy

Microcurrent therapy, type B

ACTIVE COMPARATOR

Microcurrent therapy: Channel A: 25 µA; 200 Hz; Channel B: 100 µA; 300 Hz. Duration of each treatment session: 30 minutes. Number of sessions: 10. Previous treatments will be continued.

Device: Microcurrent therapy

Sham Microcurrent therapy

SHAM COMPARATOR

Microcurrent therapy: Channel A: 0 µA; 0 Hz; Channel B: 0 µA; 0 Hz. Duration of each treatment session: 30 minutes. Number of sessions: 10. Previous treatments will be continued.

Device: Microcurrent therapy

No Intervention

NO INTERVENTION

No Intervention. Previous treatments will be continued.

Interventions

The microcurrent therapy will be applied with electrodes that are fixed around the knee. The two electrodes of channel A will be placed at the inner and outer side of the knee that is most affected by pain. The two electrodes of channel B will be placed above and below the patella. An apparatus with CE certificate will be used.

Microcurrent therapy, type AMicrocurrent therapy, type BSham Microcurrent therapy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • osteoarthritis of the knee
  • pain intensity \> 3 on the numerical rating scale (0-10)

You may not qualify if:

  • knee arthroplasty
  • gravity
  • dermal Irritation at the skin of the knee
  • carcinoma
  • known osteoarthritis grade 4 (Kellgren and Lawrence score)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ludwig Maximilian University, University Hosipital, Department of Orthopedics, Physical Medicine and Rehabilitation

Munich, 81377, Germany

Location

MeSH Terms

Conditions

Osteoarthritis, KneeOsteoarthritis

Condition Hierarchy (Ancestors)

ArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Martin B Weigl

    Department of Orthopedics, Physical Medicine and Rehabilitation, University Hospital Munich, Ludwig Maximilians University Munich

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PD, MD, MPH (Harvard University)

Study Record Dates

First Submitted

November 21, 2016

First Posted

November 29, 2016

Study Start

December 5, 2016

Primary Completion

September 4, 2017

Study Completion

September 4, 2017

Last Updated

October 12, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations